"
Team:Wisconsin-Madison/advisors
From 2013.igem.org
Cbjohnson4 (Talk | contribs) |
Cbjohnson4 (Talk | contribs) |
||
| (One intermediate revision not shown) | |||
| Line 19: | Line 19: | ||
| - | <h2 align="left" class="classtheinlinecontent"><strong style="font-style:italic">Brian F. Pfleger, PhD </strong></h2> <br><p class="classtheinlinecontent2" align="left">Brian Pfleger is an Assistant Professor in the Department of Chemical and Biological Engineering of University of Wisconsin Madison. His lab's current interest is using synthetic biology to engineer sustainable chemical processes and to improve human health. He believes synthetic biology is an emerging biotechnology field that combines elements of engineering, mathematics, biochemistry, and biology to synthesize novel systems from characterized biological components. His research lab integrates these scientific disciplines to engineer chemical production platforms in microorganisms. The lab’s work strives to characterize new biological components, synthesize novel activities and novel molecules from cataloged components, and provide tools to analyze biological systems. His long term vision of the chemical industry involves the use of modern biotechnology, and specifically synthetic biology, to engineer systems where the spectrum of fuels, chemicals, and pharmaceuticals we use can be produced from renewable sources such as biomass or CO2.</p> | + | <h2 align="left" class="classtheinlinecontent"><strong style="font-style:italic">Brian F. Pfleger, PhD </strong></h2> <br><p class="classtheinlinecontent2" align="left">Brian Pfleger is an Assistant Professor in the Department of Chemical and Biological Engineering of University of Wisconsin Madison. His lab's current interest is using synthetic biology to engineer sustainable chemical processes and to improve human health. He believes synthetic biology is an emerging biotechnology field that combines elements of engineering, mathematics, biochemistry, and biology to synthesize novel systems from characterized biological components. His research lab integrates these scientific disciplines to engineer chemical production platforms in microorganisms. The lab’s work strives to characterize new biological components, synthesize novel activities and novel molecules from cataloged components, and provide tools to analyze biological systems. His long term vision of the chemical industry involves the use of modern biotechnology, and specifically synthetic biology, to engineer systems where the spectrum of fuels, chemicals, and pharmaceuticals we use can be produced from renewable sources such as biomass or CO2.</p> |
Latest revision as of 17:27, 26 September 2013
Matt Copeland, PhD
Matt received his PhD in Biochemistry from the University of Wisconsin-Madison studying the physiology and dynamics of bacterial flagella during swarming motility. He is currently a postdoctoral fellow in Dr. Brian Pfleger's lab working on the development of trans-acting regulatory tools to manipulate gene expression for the fields of synthetic biology and metabolic engineering.
Brian F. Pfleger, PhD
Brian Pfleger is an Assistant Professor in the Department of Chemical and Biological Engineering of University of Wisconsin Madison. His lab's current interest is using synthetic biology to engineer sustainable chemical processes and to improve human health. He believes synthetic biology is an emerging biotechnology field that combines elements of engineering, mathematics, biochemistry, and biology to synthesize novel systems from characterized biological components. His research lab integrates these scientific disciplines to engineer chemical production platforms in microorganisms. The lab’s work strives to characterize new biological components, synthesize novel activities and novel molecules from cataloged components, and provide tools to analyze biological systems. His long term vision of the chemical industry involves the use of modern biotechnology, and specifically synthetic biology, to engineer systems where the spectrum of fuels, chemicals, and pharmaceuticals we use can be produced from renewable sources such as biomass or CO2.
Charles Johnson
Charles is a Senior in the department of Chemical and Biological Engineering at UW-Madison. He is interested in studying the many different ways synthetic biology can be used to help the world, from medical applications to biofuels. When Charlie is not in the lab he wants follow in his family's footsteps by helping those less fortunate than him. His older brother and grandmother dedicated their lives to teaching in the inner city of Chicago, while his parents have been representing people who could not afford lawyers for 30 plus years. His younger brother works in a group home helping abused and neglected children find a safe place to live and learn.
